PL356817A1 - Aerozol kropelkowy -IFN i sposób - Google Patents

Aerozol kropelkowy -IFN i sposób

Info

Publication number
PL356817A1
PL356817A1 PL00356817A PL35681700A PL356817A1 PL 356817 A1 PL356817 A1 PL 356817A1 PL 00356817 A PL00356817 A PL 00356817A PL 35681700 A PL35681700 A PL 35681700A PL 356817 A1 PL356817 A1 PL 356817A1
Authority
PL
Poland
Prior art keywords
gamma
ifn
aerosol
solution
aqueous
Prior art date
Application number
PL00356817A
Other languages
English (en)
Inventor
J.Woodruff Emlen
Vlasselaer Peter Van
Original Assignee
Intermune Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermune Inc. filed Critical Intermune Inc.
Publication of PL356817A1 publication Critical patent/PL356817A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL00356817A 1999-12-30 2000-12-22 Aerozol kropelkowy -IFN i sposób PL356817A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17392699P 1999-12-30 1999-12-30
PCT/US2000/042831 WO2001049260A2 (en) 1999-12-30 2000-12-22 Y-ifn liquid-droplet aerosol and method

Publications (1)

Publication Number Publication Date
PL356817A1 true PL356817A1 (pl) 2004-07-12

Family

ID=22634096

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356817A PL356817A1 (pl) 1999-12-30 2000-12-22 Aerozol kropelkowy -IFN i sposób

Country Status (18)

Country Link
US (1) US20010043906A1 (pl)
EP (1) EP1286658B1 (pl)
JP (1) JP2003519169A (pl)
KR (1) KR20020072563A (pl)
CN (1) CN1230197C (pl)
AT (1) ATE319424T1 (pl)
AU (1) AU4525801A (pl)
BR (1) BR0016884A (pl)
CA (1) CA2395803A1 (pl)
CZ (1) CZ20022220A3 (pl)
DE (1) DE60026618T2 (pl)
HK (1) HK1052876B (pl)
MX (1) MXPA02006518A (pl)
NO (1) NO20023135L (pl)
NZ (1) NZ519773A (pl)
PL (1) PL356817A1 (pl)
WO (1) WO2001049260A2 (pl)
ZA (1) ZA200205167B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6883516B2 (en) * 2000-04-27 2005-04-26 Chrysalis Technologies Incorporated Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
US6964761B1 (en) * 2001-12-12 2005-11-15 New York University Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-γ
DE10218328A1 (de) * 2002-03-05 2003-09-25 Humboldt Uni Zu Berlin Medizin Mittel zur präventiven Therapie nach akutem Schlaganfall
US20050232899A1 (en) * 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US6830744B2 (en) 2002-05-31 2004-12-14 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
AU2002330801A1 (en) * 2002-06-20 2004-01-06 Igor Anatolievich Pomytkin Method for oral transmucosal delivery of interferon
US20040235308A1 (en) 2003-05-22 2004-11-25 Dainippon Screen Mfg. Co., Ltd. Substrate treatment method and sustrate treatment apparatus
CA2567056A1 (en) * 2004-05-10 2005-12-08 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
US20070065367A1 (en) * 2005-09-20 2007-03-22 Rany Condos Method of treating pulmonary disease with interferons
CN103550757A (zh) * 2005-09-20 2014-02-05 纽约大学 用干扰素治疗肺病的方法
US8105571B2 (en) * 2005-09-20 2012-01-31 New York University Method of treating pulmonary disease with interferons
US8105572B2 (en) * 2007-05-18 2012-01-31 New York University Method of treating tuberculosis with interferons
BRPI0520564A2 (pt) * 2005-09-20 2009-05-19 Univ New York método de tratar doença pulmonar com interferons apoio governamental
WO2008143892A1 (en) * 2007-05-18 2008-11-27 New York University Method of treating tuberculosis with interferons
US8557485B2 (en) * 2008-12-11 2013-10-15 GM Global Technology Operations LLC Tungsten-containing hydrogen-storage materials for anodes of PEM fuel cells
JP2012193207A (ja) * 2012-07-13 2012-10-11 New York Univ インターフェロンを用いる肺疾患の処置方法
WO2016169571A1 (en) * 2015-04-20 2016-10-27 Ghaleb Haider Abbas Pharmaceutical product for treatment & prophylaxis of viral/ microbial infection
CN113491807B (zh) * 2020-04-03 2023-07-28 深圳麦克韦尔科技有限公司 一种气溶胶产生装置
CN116251174B (zh) * 2022-12-23 2023-09-29 北京三元基因药业股份有限公司 一种包含人干扰素α1b吸入溶液的药物组件

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2032831T5 (es) * 1986-08-19 2001-02-16 Genentech Inc Dispositivo y dispersion para suministro intrapulmonar de factores de crecimiento polipeptidos y citoquinas.
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5780012A (en) * 1990-06-21 1998-07-14 Huland; Edith Method for reducing lung afflictions by inhalation of cytokine solutions
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
US5855564A (en) * 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism

Also Published As

Publication number Publication date
AU4525801A (en) 2001-07-16
WO2001049260A2 (en) 2001-07-12
ZA200205167B (en) 2003-11-05
DE60026618D1 (de) 2006-05-04
EP1286658A2 (en) 2003-03-05
KR20020072563A (ko) 2002-09-16
HK1052876A1 (en) 2003-10-03
WO2001049260A3 (en) 2002-02-07
NZ519773A (en) 2005-02-25
CN1230197C (zh) 2005-12-07
DE60026618T2 (de) 2007-01-18
JP2003519169A (ja) 2003-06-17
EP1286658B1 (en) 2006-03-08
CN1434701A (zh) 2003-08-06
BR0016884A (pt) 2002-10-01
CZ20022220A3 (cs) 2003-01-15
NO20023135D0 (no) 2002-06-27
MXPA02006518A (es) 2004-07-30
ATE319424T1 (de) 2006-03-15
NO20023135L (no) 2002-08-23
CA2395803A1 (en) 2001-07-12
HK1052876B (en) 2006-06-16
US20010043906A1 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
ZA200205167B (en) gamma-IFN liquid-droplet aerosol and method.
GEP20043259B (en) Device for Delivery of Aerosolized Active Agent to the Lung of a Human Patient
IL112269A (en) Adhesive compositions for use in transdermal drug delivery systems and method of their preparation
BG104720A (en) Aerosolized active agent delivery
EP1138275A3 (en) Multiple solution dental irrigator
IL112516A0 (en) Thyroid hormone liquid pharmaceutical composition
GEP20043258B (en) Systems and Methods for Aerosolizing Pharmaceutical Formulations
EP2255806A3 (en) Fentanyl composition for nasal administration
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
WO2002024261A3 (en) Shock wave aerosolization apparatus and method
AU3598299A (en) Improved compositions for inhalation
NZ513981A (en) Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
DE69527713D1 (de) Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung
UA29890A (uk) Краплі для очей "вінісан"
MX9705185A (es) Particula de resina, material medico y preparacion farmaceutica que contiene dicha particula de resina.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)